A Study of SHR6390 in Combination With Letrozole or Anastrozole or Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast Cancer
Clinical trial NCT03481998 · COMPLETED
Trial details
- NCT number
- NCT03481998
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-22
- Primary completion
- 2022-07-30
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.